netFormulary NHS
Nottinghamshire Area Prescribing Committee
Joint Formulary
 Search
 Results

Looking for Atezolizumab found 8 matches
Open monograph to display formulary status BNF Category
  Restricted Drug Atezolizumab  (Tecentriq®) Malignant disease and immunosuppression - Other antineoplastic drugs - 08.01.05
 


Linkslink in drug section Link to Drug Section link in subsection Link to document
link in drug section EAMS 00031/0012: Atezolizumab in combination with bevacizumab for the treatment of adult patients with unresectable hepatocellular carcinoma who have received no prior systemic therapy  (08.01.05)
link in drug section NICE TA492: Atezolizumab for untreated locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (08.01.05)
link in drug section NICE TA520: Atezolizumab for treating locally advanced or metastatic non-small-cell lung cancer after chemotherapy (08.01.05)
link in drug section NICE TA525: Atezolizumab for treating locally advanced or metastatic urothelial carcinoma after platinum-containing chemotherapy. (08.01.05)
link in drug section NICE TA584:Atezolizumab in combination for treating metastatic non-squamous non-small-cell lung cancer (08.01.05)
link in drug section NICE TA638: Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer (08.01.05)
link in drug section NICE TA639: Atezolizumab with nab-paclitaxel for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer  (08.01.05)


 
netFormulary